POLR1C helps your cells make RNAs needed to build ribosomes, the structures that make proteins. Every cell in your body uses this gene to support growth and repair. If POLR1C does not work well, these building blocks can be in short supply, which may affect brain development and myelin (the insulation around nerves). Pathogenic variants in the POLR1C gene can cause rare inherited conditions such as POLR3-related leukodystrophy and, less often, Treacher Collins syndrome. Many POLR1C variants are harmless, so results are interpreted alongside symptoms and family history.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage activities in the body. Many genes provide the directions for building proteins, which act as the cell’s functional tools. Some genes are more focused on regulation, helping set the timing, location, and strength of specific processes. In combination, genes affect how your body grows and works, and they can influence how you react to food, stress, or medicines. For a deeper look at this subject, you can read more in the LearnHub.
Overview
POLR1CGene function
What if the gene works
The POLR1C gene helps your cells make key RNA molecules needed to build ribosomes, the structures that assemble proteins. By supporting RNA polymerase I and III activity, it helps keep growth and routine cell function running smoothly.
Risk
What if the gene does not work
With two altered copies of the POLR1C gene, some people develop hypomyelinating leukodystrophy, with childhood-onset balance trouble, stiffness, and movement challenges. DNA changes range from milder variants to severe mutations, which can affect age of onset and symptom severity.
Treatment
What does that mean for your treatment
Most treatment is focused on symptoms; variants in the POLR1C gene usually do not point to a specific medication or predict drug response. Results can still guide monitoring, supportive therapies, and access to specialists or clinical trials.
Conditions associated with POLR1C
Gene function
What if the gene works
Every cell needs a steady supply of RNA to build ribosomes and keep protein production running. The POLR1C gene function supports two of the cell’s main RNA-making machines, which copy DNA instructions into RNA. This everyday work helps cells grow, renew, and handle routine demands.
The POLR1C gene helps RNA polymerase I (a major RNA-making enzyme) produce ribosomal RNA, a key building block of ribosomes. Ribosomes are the cell’s protein-making factories, so this supports normal cell upkeep and growth.
The POLR1C gene also supports RNA polymerase III, which makes small RNAs such as transfer RNAs that deliver amino acids during protein building. It also helps produce 5S ribosomal RNA, another piece needed to assemble working ribosomes.
The POLR1C gene provides a protein part that helps these RNA-making enzymes form correctly and work steadily. This supports smooth, consistent RNA output so cells can match everyday needs for growth and maintenance.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. Variants are widespread and help explain typical human differences, such as variation in appearance, metabolism, or the way the body reacts to environmental factors. Many variants do not cause any obvious changes and are part of normal genetic diversity. In certain situations, though, a variant can affect how a gene works more strongly and may play a role in, or lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the POLR1C gene can lower how well cells make RNA messages needed for growth and nervous system wiring. A POLR1C gene mutation may partly reduce this activity or, with more disruptive mutations, stop it almost completely, which can shift symptoms from milder to more pronounced. Depending on the variant and whether one or two copies are affected, people may have facial and jaw differences (Treacher Collins syndrome) or brain white matter changes (a POLR3-related leukodystrophy).
How variants are linked to conditions
Pathogenic variants in the POLR1C gene can lead to POLR1C-related 4H leukodystrophy, a condition affecting brain white matter that often involves movement, balance, and hormone-related symptoms. Other POLR1C gene changes can cause Treacher Collins syndrome, which affects facial bone development and hearing. Which condition occurs depends on the specific variant and inheritance pattern.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology, and many people in the general population carry them. In most cases, these variants do not directly affect health and instead reflect natural differences among individuals. For many genes, having a variant that has been linked to a condition points to a potential association rather than a certain diagnosis, particularly when many genes and environmental influences contribute. In other situations, a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For POLR1C-related conditions, the chance of developing the condition is mostly set by the specific POLR1C changes you inherit, and day-to-day lifestyle choices are not known to meaningfully change that risk. There is not enough evidence to say that diet, supplements, or exercise lowers risk. What can change outcomes is early monitoring and prompt care for complications that can come with the condition, such as breathing, hearing, or repeated infections.
Inheritance of POLR1C variants
Most health conditions linked to changes in the POLR1C gene follow an autosomal recessive POLR1C gene inheritance pattern. This means a child is affected when they inherit two nonworking copies, usually one from each parent, who are typically healthy carriers. When both parents are carriers, each pregnancy has a 25% chance of an affected child and a 50% chance of a carrier child.
What does my POLR1C result mean for my family?
If you or a close relative has a disease linked to the POLR1C gene, medical advice can help you understand what it may mean for siblings, children, and future pregnancies. Seek care sooner if a baby or child has early hearing problems, frequent serious infections, or slow growth, or if symptoms are getting worse. A POLR1C result can also affect care plans, so bring it to your next visit and ask how it should guide follow-up and treatment.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the POLR1C gene, a clinician can order POLR1C genetic testing using a blood draw or saliva sample. A laboratory reads your DNA with sequencing to look for variants and may confirm important findings with a second method. Results are reported in categories and interpreted alongside your symptoms and family history.
When should I consider getting a genetic test?
Consider testing the POLR1C gene when you or your child has a pattern of symptoms that suggests a rare inherited condition, such as worsening balance or stiffness, learning or movement delays, or certain face and jaw differences present from birth. Testing can also help when a brain scan shows unusual changes without a clear cause. It can be useful with a known POLR1C change in the family or when planning a pregnancy.
A genetic result is only one part of your health story
A genetic test result can be useful, but the amount of information it provides varies with the health condition and the specific kind of variant found. How your body functions over time is also shaped by factors like lifestyle, environment, age, and your medical history. For certain conditions, particularly those affected by many genes, genetic findings tend to offer context rather than a definite prediction and make the most sense when considered with other parts of your care. In other situations, the result can be more straightforward and give a clear explanation. When it comes to how you respond to medications, genetic information can also help interpret individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how you respond to a medication, including how well it works and how likely side effects are. Many of these differences come from genes that affect how the body breaks down drugs, moves them into or out of cells, or how strongly a drug acts on its target. The POLR1C gene mainly supports basic cell function by helping cells make RNA (a key step in making proteins), so medication response is usually shaped more by other genes and by factors like age, other medicines, liver and kidney health, and overall health. Genetic results, when available, are one part of the larger picture clinicians use to understand why the same treatment can feel different from one person to another.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can affect the way a person responds to medicines. It focuses on relationships between specific genes and specific drugs to explain why the same treatment can have different effects in different people. For many medications, your genes can influence how your body breaks down a drug or how much effect the drug has. Understanding these gene drug connections can support more informed and more personalized treatment choices. More information on this topic is available in the LearnHub.
Drugs influenced by the POLR1C gene
When should I seek medical advice?
Seek medical advice if you or your child has a known change in the POLR1C gene and new or worsening nerve-related problems appear, such as changes in walking, balance, speech, vision, or unexplained shaking. Get help promptly for sudden weakness, trouble swallowing, or breathing problems. Talk with your care team before major procedures or new medicines, since care plans may need adjusting.
History
The POLR1C gene was first characterized as part of the machinery cells use to make essential RNA, and it was studied for years mainly in basic genetics research. In recent decades, awareness of this gene’s role has grown as researchers began linking POLR1C changes to specific inherited conditions. In the early 2010s, studies connected certain POLR1C variants to a form of childhood-onset white matter disease sometimes called 4H leukodystrophy, which helped clarify the genetic cause for some affected families. Around the same period, other research reports linked different POLR1C variants to Treacher Collins syndrome in some people, expanding the list of genes involved in this craniofacial condition. These findings supported broader use of gene panels that include POLR1C when clinicians evaluate these diagnoses.